These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29310056)

  • 1. Residual pulmonary vascular obstruction as predictor of pulmonary embolism recurrence after a first unprovoked episode.
    Karathanos C; Spanos K; Giannoukas A
    Thromb Res; 2018 Feb; 162():77-78. PubMed ID: 29310056
    [No Abstract]   [Full Text] [Related]  

  • 2. Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study.
    Wan T; Rodger M; Zeng W; Robin P; Righini M; Kovacs MJ; Tan M; Carrier M; Kahn SR; Wells PS; Anderson DR; Chagnon I; Solymoss S; Crowther M; White RH; Vickars L; Bazarjani S; Le Gal G
    Thromb Res; 2018 Feb; 162():104-109. PubMed ID: 29224973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism.
    Pesavento R; Filippi L; Palla A; Visonà A; Bova C; Marzolo M; Porro F; Villalta S; Ciammaichella M; Bucherini E; Nante G; Battistelli S; Muiesan ML; Beltramello G; Prisco D; Casazza F; Ageno W; Palareti G; Quintavalla R; Monti S; Mumoli N; Zanatta N; Cappelli R; Cattaneo M; Moretti V; Corà F; Bazzan M; Ghirarduzzi A; Frigo AC; Miniati M; Prandoni P;
    Eur Respir J; 2017 May; 49(5):. PubMed ID: 28546279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of recurrent venous thromboembolism and chronic thromboembolic pulmonary hypertension following a first episode of pulmonary embolism.
    Poli D; Miniati M
    Curr Opin Pulm Med; 2011 Sep; 17(5):392-7. PubMed ID: 21743331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism. A single center cohort study.
    Planquette B; Ferré A; Peron J; Vial-Dupuy A; Pastre J; Mourin G; Emmerich J; Collignon MA; Meyer G; Sanchez O
    Thromb Res; 2016 Dec; 148():70-75. PubMed ID: 27815969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism.
    Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; LE Gal G; Solymoss S; Crowther M; Perrier A; Ramsay T; Betancourt MT; White RH; Vickars L; Rodger MA
    J Thromb Haemost; 2010 Sep; 8(9):1926-32. PubMed ID: 20561184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
    Couturaud F; Sanchez O; Pernod G; Mismetti P; Jego P; Duhamel E; Provost K; dit Sollier CB; Presles E; Castellant P; Parent F; Salaun PY; Bressollette L; Nonent M; Lorillon P; Girard P; Lacut K; Guégan M; Bosson JL; Laporte S; Leroyer C; Décousus H; Meyer G; Mottier D;
    JAMA; 2015 Jul; 314(1):31-40. PubMed ID: 26151264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indefinite anticoagulation after a first episode of unprovoked venous thromboembolism: yes.
    Kearon C
    J Thromb Haemost; 2007 Dec; 5(12):2330-5. PubMed ID: 18034763
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism: Findings from a long-term follow-up study.
    Zhang S; Zhai Z; Yang Y; Zhu J; Kuang T; Xie W; Yang S; Liu F; Gong J; Shen YH; Wang C
    Int J Cardiol; 2016 Jan; 202():275-81. PubMed ID: 26408837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of recurrence in patients with pulmonary embolism: predictive role of D-dimer and of residual perfusion defects on lung scintigraphy.
    Poli D; Cenci C; Antonucci E; Grifoni E; Arcangeli C; Prisco D; Abbate R; Miniati M
    Thromb Haemost; 2013 Feb; 109(2):181-6. PubMed ID: 23196319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
    Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
    J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticoagulation after an acute pulmonary embolism].
    Le Mao R; Tromeur C; Couturaud F
    Presse Med; 2017; 46(7-8 Pt 1):728-738. PubMed ID: 28756076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
    Prandoni P; Barbar S; Milan M; Vedovetto V; Pesavento R
    Eur J Intern Med; 2014 Jan; 25(1):25-30. PubMed ID: 24120221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study.
    Caiano L; Sharkey R; Rodger MA; Kovacs MJ; Le Gal G; Delluc A
    Eur Respir J; 2022 Feb; 59(2):. PubMed ID: 34795036
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimal duration of anticoagulation in patients with unprovoked venous thromboembolism: the impact of novel anticoagulants.
    Prandoni P; Milan M; Sarolo L; Zanon E; Bilora F
    Int Angiol; 2017 Oct; 36(5):395-401. PubMed ID: 27982558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
    Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R
    Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of 117 cases of unprovoked pulmonary embolism and further investigation in patients over 40.
    Angwin C; Rochester A; Jawad M
    Clin Med (Lond); 2020 Mar; 20(Suppl 2):s64. PubMed ID: 32409382
    [No Abstract]   [Full Text] [Related]  

  • 18. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F
    Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of residual pulmonary vascular obstruction after pulmonary embolism: Results from a prospective cohort study.
    Picart G; Robin P; Tromeur C; Orione C; Raj L; Ferrière N; Le Mao R; Le Roux PY; Le Floch PY; Lemarié CA; Nonent M; Leroyer C; Guegan M; Lacut K; Salaün PY; Couturaud F
    Thromb Res; 2020 Oct; 194():1-7. PubMed ID: 32554255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term prognostic value of residual pulmonary vascular obstruction at discharge in patients with intermediate- to high-risk pulmonary embolism.
    Meneveau N; Ider O; Seronde MF; Chopard R; Davani S; Bernard Y; Schiele F
    Eur Heart J; 2013 Mar; 34(9):693-701. PubMed ID: 23103660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.